TCRR News and Press, TCR2 Therapeutics Inc. From 08/10/19

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

TCR2 Therapeutics (NASDAQ: TCRR ): Q2 GAAP EPS of -$0.46 beats by $0.03 . More news on: TCR2 Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Began dosing of TC-210 in the Phase 1/2 trial for patients with mesothelin-expressing solid tumors and an interim update anticipated in 4Q19/1Q20 Leading clinical sites participating in the TC-210 trial include Sarah Cannon Research Institute, MD Anderson Cancer Center and the National Ca...

CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced that management will participate in two upcoming i...

Expansion of leadership team to support clinical trials with an emphasis on manufacturing, IND enablement and development of next generation of TRuC-T cells CAMBRIDGE, Mass., Aug. 06, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy compa...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) declined again last week, falling from 3,323.71 points on Monday’s (July 29) open to 3,282.81 points as of 1:22 p.m. EDT on Friday (August 2). Over the course of the week, a number of top companies released pivotal Q2 2019 earnings, i...

Gainers:   TCF Financial  (NYSE: TCF ) +99% . Myriad Genetics (NASDAQ: MYGN ) +52% . SunPower (NASDAQ: SPWR ) +33% . the Rubicon Project (NYSE: RUBI ) +31% . Vanda Pharmaceuticals (NASDAQ: VNDA ) +29% . NIC (NASDAQ: EGOV ) +24% . TCR2 Therapeutics (NASDAQ: TCRR ) ...

CAMBRIDGE, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced that it has entered into a Cooperative Research an...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was in the red again last week, falling from 3,283.64 points on Monday’s (July 22) open to 3,283.82 points as of 1:58 p.m. EDT on Friday (July 26). On Thursday (July 25),  news hit that the US Food and Drug Administration (FDA) ...

Gainers : Anika Therapeutics (NASDAQ: ANIK ) +34% . TCR2 Therapeutics (NASDAQ: TCRR ) +30% . Diebold Nixdorf (NYSE: DBD ) +26% . EDAP TMS (NASDAQ: EDAP ) +20% . Hovnanian (NYSE: HOV ) +18%.  NETGEAR (NASDAQ: NTGR ) +16% . Meritage Homes (NYSE: MTH ) +16% . Empire Resorts (NASDA...